VRTX fund manager activity
Vertex Pharmaceuticals Incorporated · Nasdaq. Reported by 12 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | Trimmed | 6,000 | $2,980,380 | 0.00% | Aug 14, 2026 |
| Ken Fisher - Fisher Asset Management | Trimmed | 24,478 | $12,159,237 | 0.00% | Aug 4, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 18,986 | $9,430,916 | 0.02% | Aug 14, 2026 |
| Torray Funds | Trimmed | 15,215 | $7,557,747 | 1.02% | Jul 30, 2026 |
| Tweedy Browne | Trimmed | 40,121 | $19,929,304 | 1.51% | Aug 7, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | Added | 7,500 | $3,349,050 | 0.01% | May 15, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 31,158 | $13,913,603 | 0.00% | May 5, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 20,887 | $9,326,881 | 0.03% | May 15, 2026 |
| Torray Funds | Trimmed | 15,386 | $6,870,464 | 1.01% | May 1, 2026 |
| Tweedy Browne | Added | 40,387 | $18,034,411 | 1.43% | May 6, 2026 |
Older quarters